Vanguard Group’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Buy |
1,471,574
+44,107
| +3% | +$149K | ﹤0.01% | 3222 |
|
|
2025
Q1 | $5.51M | Sell |
1,427,467
-3,278
| -0.2% | -$12.7K | ﹤0.01% | 3132 |
|
|
2024
Q4 | $8.83M | Buy |
1,430,745
+36,721
| +3% | +$227K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $7.5M | Buy |
1,394,024
+97,236
| +7% | +$523K | ﹤0.01% | 3097 |
|
|
2024
Q2 | $4.34M | Buy |
1,296,788
+10,826
| +0.8% | +$36.3K | ﹤0.01% | 3313 |
|
|
2024
Q1 | $5.18M | Buy |
1,285,962
+288,803
| +29% | +$1.16M | ﹤0.01% | 3289 |
|
|
2023
Q4 | $2.64M | Buy |
997,159
+10,448
| +1% | +$27.7K | ﹤0.01% | 3503 |
|
|
2023
Q3 | $2.33M | Buy |
986,711
+3,437
| +0.3% | +$8.11K | ﹤0.01% | 3528 |
|
|
2023
Q2 | $6.19M | Sell |
983,274
-299,769
| -23% | -$1.89M | ﹤0.01% | 3203 |
|
|
2023
Q1 | $7.4M | Sell |
1,283,043
-278,657
| -18% | -$1.61M | ﹤0.01% | 3109 |
|
|
2022
Q4 | $16M | Buy |
1,561,700
+9,950
| +0.6% | +$102K | ﹤0.01% | 2732 |
|
|
2022
Q3 | $25.9M | Buy |
1,551,750
+271,706
| +21% | +$4.54M | ﹤0.01% | 2518 |
|
|
2022
Q2 | $17.9M | Sell |
1,280,044
-593,849
| -32% | -$8.31M | ﹤0.01% | 2692 |
|
|
2022
Q1 | $30.3M | Buy |
1,873,893
+3,391
| +0.2% | +$54.8K | ﹤0.01% | 2558 |
|
|
2021
Q4 | $40M | Buy |
1,870,502
+782,301
| +72% | +$16.7M | ﹤0.01% | 2476 |
|
|
2021
Q3 | $16M | Sell |
1,088,201
-117,765
| -10% | -$1.73M | ﹤0.01% | 2985 |
|
|
2021
Q2 | $24M | Buy |
1,205,966
+1,080,975
| +865% | +$21.5M | ﹤0.01% | 2753 |
|
|
2021
Q1 | $3.74M | Buy |
+124,991
| New | +$3.74M | ﹤0.01% | 3672 |
|